$0.21
-0.01 (-4.31%)
USD · as of 2026-08-19 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where VTAK is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 interventional · 1 observational
Held by 0 tracked-famous managers · FINRA short interest 1.0 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| VIVO European Observational RegistryNCT04990089observationalMeasure the effectiveness of VIVO within different types of VA procedures | — | Completed | Device: VIVO | Ventricular Arrythmia, Ventricular Tachycardia, Premature Ventricular Contraction | 125 | 2024-06-28actual | 2025-01-31 |
| VIVO™ Accuracy StudyNCT03340142Accuracy of correctly identifying PVC or VT originOpen-label · Diagnostic | Not applicable | Completed | Device: VIVO™ | Premature Ventricular Contraction, Ventricular Tachycardia | 45 | 2018-09-04actual | 2018-11-15 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19